Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
This lecture delves into the mechanisms of sustained proliferation in cancer, focusing on the RTK/PI3K/mTOR pathway and its inhibitors like Trastuzumab, Lapatinib, and Gefitinib. It explores the activation of PI3K by p-RTK and Ras, the completed randomized trials of PI3K and AKT inhibitors in breast cancer, and the effects of Akt/PKB on survival, proliferation, and cell growth. The lecture also covers the canonical Wnt/ß-catenin signaling pathway, Familial Adenomatous Polyposis (FAP), and the role of GPCRs and G-proteins in human cancers. It concludes by discussing the progression of colorectal cancer and the additional hallmark capabilities required for its development.